Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel patent CN106588932B offers high-yield tenofovir intermediate synthesis. Reduces cost and improves supply chain reliability for pharmaceutical manufacturers globally.
Novel amidation-first route for Capecitabine synthesis improves yield to 68% and purity. Cost-effective supply chain solution for oncology APIs.
Advanced chiral synthesis patent CN106699604B offers high purity Sacubitril Intermediate. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical partners.
Patent CN116554000B reveals rhodium-catalyzed indenol synthesis. Enhances enantioselectivity and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN115197188B reveals efficient synthesis of pentacyclic sesquiterpene hydroquinones. Discover cost-effective manufacturing and scalable supply chain solutions.
Discover the patented CN101006064B process for Irbesartan. This report analyzes the novel reductive alkylation route, offering significant cost reduction in API manufacturing and enhanced supply chain stability.
Novel acid-catalyzed route eliminates transition metals ensuring high purity pharmaceutical intermediates. Significant cost reduction and supply chain reliability for global procurement teams seeking scalable solutions.
Patent CN102267985A reveals a scalable route for Vilazodone HCl, eliminating hazardous Lewis acids and precious metals for cost-effective pharmaceutical manufacturing.
Patent CN121517448A reveals copper-catalyzed synthesis for high-purity pharmaceutical intermediates. Enables cost reduction and scalable supply chain reliability.
Patent CN103193679B enables high ee value asymmetric hydrogenation for Rivastigmine intermediate, ensuring cost reduction and supply reliability.
Patent CN112979545B reveals a metal-free route to 5-selenoquinolines using PIFA. This method offers high regioselectivity and mild conditions for reliable pharmaceutical intermediate supply.
Novel visible light catalysis method for indol-3-one derivatives. Offers mild conditions and high yield for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN110747489B reveals a novel electroreduction method for 2-amino-4-methoxybenzoic acid derivatives, offering high-purity intermediates for Gefitinib with reduced environmental impact.
Patent CN118439917A reveals a novel Pd-catalyzed decarboxylation method using SO2F2. This technology offers high-purity styrene compounds with significant supply chain and cost advantages for global manufacturers.
Patent CN111763157B reveals a novel one-step asymmetric synthesis for chiral amino compounds, enabling cost reduction in pharmaceutical manufacturing and safer scale-up.
Discover a novel [3+3] cycloaddition route for chiral spiro-1,4-benzodiazepine-2-ones. Efficient synthesis with high stereoselectivity for pharmaceutical applications.
Patent CN116969824B reveals green synthesis for cefdinir intermediate offering high purity yield and supply chain stability for pharmaceutical manufacturing.
Patent CN103772189A details a scalable 13-step synthesis for Methyl Cajanonic Acid A, offering a robust alternative to natural extraction for hypoglycemic drug development.
This report analyzes patent CN109761882A for Carprofen synthesis offering significant supply chain stability and cost reduction benefits for global veterinary pharmaceutical manufacturers.
Advanced synthetic route for 8-Boc-6,7,8,9-tetrahydro-5H-imidazo[1,5-a][1,4]diazepine-6-carboxylic acid. Optimized for high purity, scalable manufacturing, and cost-effective pharmaceutical intermediate supply.